{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T02:02:16Z","timestamp":1780020136469,"version":"3.53.1"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Veterinary Journal"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.tvjl.2026.106703","type":"journal-article","created":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T00:27:15Z","timestamp":1778891235000},"page":"106703","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Overcoming mirtazapine's therapeutic limitations in veterinary practice: Development of a taste\u00a0-\u00a0masked orally disintegrating tablet with microsphere-based controlled release"],"prefix":"10.1016","volume":"317","author":[{"given":"Yitong","family":"Lu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yajing","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanjin","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yifan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9333-5130","authenticated-orcid":false,"given":"Zhiyong","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tvjl.2026.106703_bib1","doi-asserted-by":"crossref","first-page":"267","DOI":"10.2174\/1567201814666170320143824","article-title":"Geriatric-oriented high dose nutraceutical odts: formulation and physicomechanical characterization","volume":"15","author":"Agiba","year":"2018","journal-title":"Current Drug delivery"},{"key":"10.1016\/j.tvjl.2026.106703_bib2","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1177\/1098612X14545273","article-title":"Pharmacological appetite stimulation: rational choices in the inappetent cat","volume":"16","author":"Agnew","year":"2014","journal-title":"Journal of Feline Medicine and Surgery"},{"key":"10.1016\/j.tvjl.2026.106703_bib3","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1111\/jvp.12946","article-title":"Recent advances in microencapsulation of drugs for veterinary applications","volume":"44","author":"Ahmad","year":"2021","journal-title":"Journal of veterinary pharmacology and therapeutics"},{"key":"10.1016\/j.tvjl.2026.106703_bib4","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1517\/17460441.2014.941802","article-title":"Challenges and emerging solutions in the development of compressed orally disintegrating tablets","volume":"9","author":"Al-Khattawi","year":"2014","journal-title":"Expert Opinion on Drug Discovery"},{"key":"10.1016\/j.tvjl.2026.106703_bib5","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1111\/j.1527-3458.2001.tb00198.x","article-title":"A review of the pharmacological and clinical profile of mirtazapine","volume":"7","author":"Anttila","year":"2001","journal-title":"CNS Drug Reviews"},{"key":"10.1016\/j.tvjl.2026.106703_bib6","doi-asserted-by":"crossref","first-page":"26","DOI":"10.2174\/187221109787158364","article-title":"Trends in pharmaceutical taste masking technologies: a patent review","volume":"3","author":"Ayenew","year":"2009","journal-title":"Recent Patents on Drug Delivery formulation"},{"key":"10.1016\/j.tvjl.2026.106703_bib7","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1177\/1098612X16667168","article-title":"Drug exposure and clinical effect of transdermal mirtazapine in healthy young cats: a pilot study","volume":"19","author":"Benson","year":"2017","journal-title":"Journal of Feline Medicine and Surgery"},{"key":"10.1016\/j.tvjl.2026.106703_bib8","first-page":"437","article-title":"The practical approach to the evaluation of methods used to determine the disintegration time of orally disintegrating tablets (ODTs)","volume":"23","author":"Brniak","year":"2015","journal-title":"Saudi Pharmaceutical journal SPJ the Official Publication of the Saudi Pharmaceutical Society"},{"key":"10.1016\/j.tvjl.2026.106703_bib9","doi-asserted-by":"crossref","DOI":"10.3390\/pharmacy8040186","article-title":"Recent formulation advances and therapeutic usefulness of orally disintegrating tablets (ODTs)","volume":"8","author":"Chinwala","year":"2020","journal-title":"Pharmacy"},{"key":"10.1016\/j.tvjl.2026.106703_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.carbpol.2022.119620","article-title":"ZIF-8 enriched electrospun ethyl cellulose\/polyvinylpyrrolidone scaffolds: The key role of polyvinylpyrrolidone molecular weight","volume":"291","author":"Doustdar","year":"2022","journal-title":"Carbohydrate Polymers"},{"key":"10.1016\/j.tvjl.2026.106703_bib11","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics15041033","article-title":"Meeting Challenges of Pediatric Drug Delivery: The Potential of Orally Fast Disintegrating Tablets for Infants and Children","volume":"15","author":"Golhen","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.tvjl.2026.106703_bib12","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.colsurfb.2011.04.007","article-title":"Development and evaluation of orally disintegrating tablets (ODTs) containing Ibuprofen granules prepared by hot melt extrusion","volume":"86","author":"Gryczke","year":"2011","journal-title":"Colloids and surfaces B Biointerfaces"},{"key":"10.1016\/j.tvjl.2026.106703_bib13","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/j.jconrel.2013.09.004","article-title":"Mucoadhesive intestinal devices for oral delivery of salmon calcitonin","volume":"172","author":"Gupta","year":"2013","journal-title":"Journal of Controlled Release Official Journal of the Controlled Release Society"},{"key":"10.1016\/j.tvjl.2026.106703_bib14","doi-asserted-by":"crossref","first-page":"3754","DOI":"10.1021\/acsbiomaterials.1c00658","article-title":"Hyaluronic acid hydrogel microspheres for slow release stem cell delivery","volume":"7","author":"Hamilton","year":"2021","journal-title":"ACS Biomaterials Science & Engineering"},{"key":"10.1016\/j.tvjl.2026.106703_bib15","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.ejpb.2019.03.022","article-title":"Ultra-fast disintegrating ODTs comprising viable probiotic bacteria and HPMC as a mucoadhesive","volume":"V 139","author":"Hoffmann","year":"2019","journal-title":"European Journal of pharmaceutics and biopharmaceutics Official Journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e"},{"key":"10.1016\/j.tvjl.2026.106703_bib16","first-page":"1055","article-title":"Optimized furosemide taste masked orally disintegrating tablets","volume":"25","author":"Ibrahim","year":"2017","journal-title":"Saudi Pharmaceutical journal SPJ the Official Publication of the Saudi Pharmaceutical Society"},{"key":"10.1016\/j.tvjl.2026.106703_bib17","doi-asserted-by":"crossref","first-page":"4914","DOI":"10.1021\/acsbiomaterials.1c00615","article-title":"Angiogenic Microspheres for the Treatment of a Thin Endometrium","volume":"7","author":"Lei","year":"2021","journal-title":"ACS Biomaterials Science Engineering"},{"key":"10.1016\/j.tvjl.2026.106703_bib18","doi-asserted-by":"crossref","first-page":"897","DOI":"10.2147\/IJN.S17900","article-title":"A novel spray-dried nanoparticles-in-microparticles system for formulating scopolamine hydrobromide into orally disintegrating tablets","author":"Li","year":"2011","journal-title":"International Journal of Nanomedicine 6"},{"key":"10.1016\/j.tvjl.2026.106703_bib19","doi-asserted-by":"crossref","first-page":"360","DOI":"10.2174\/0113816128338560240923073357","article-title":"A Comprehensive Review of Challenges in Oral Drug Delivery Systems and Recent Advancements in Innovative Design Strategies","volume":"31","author":"Loke","year":"2025","journal-title":"Current Pharmaceutical Design"},{"key":"10.1016\/j.tvjl.2026.106703_bib20","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1208\/s12249-024-02760-7","article-title":"Quality-by-design based development of doxycycline hyclate-loaded polymeric microspheres for prolonged drug release","volume":"25","author":"Longre","year":"2024","journal-title":"Aaps Pharmscitech"},{"key":"10.1016\/j.tvjl.2026.106703_bib21","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-96223-9","article-title":"Optimizing ethyl cellulose-ethanol delivery towards enabling ablation of cervical dysplasia","volume":"11","author":"Mueller","year":"2021","journal-title":"Scientific Reports"},{"key":"10.1016\/j.tvjl.2026.106703_bib22","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1111\/jam.15337","article-title":"Functional fermented meat products with probiotics-A review","volume":"133","author":"Munekata","year":"2022","journal-title":"Journal of Applied Microbiology"},{"key":"10.1016\/j.tvjl.2026.106703_bib23","first-page":"11","article-title":"Ethylcellulose microparticles: a review","volume":"69","author":"Murtaza","year":"2012","journal-title":"Acta poloniae pharmaceutica"},{"key":"10.1016\/j.tvjl.2026.106703_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2022.109295","article-title":"Mirtazapine for the treatment of amphetamine and methamphetamine use disorder: a systematic review and meta-analysis","volume":"232","author":"Naji","year":"2022","journal-title":"Drug and Alcohol dependence"},{"key":"10.1016\/j.tvjl.2026.106703_bib25","doi-asserted-by":"crossref","DOI":"10.3390\/ma15062126","article-title":"Orodispersible films with rupatadine fumarate enclosed in ethylcellulose microparticles as drug delivery platform with taste-masking effect","volume":"15","author":"Olechno","year":"2022","journal-title":"Materials"},{"key":"10.1016\/j.tvjl.2026.106703_bib26","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/j.tvjl.2013.05.048","article-title":"Mirtazapine as an appetite stimulant and anti-emetic in cats with chronic kidney disease: a masked placebo-controlled crossover clinical trial","volume":"197","author":"Quimby","year":"2013","journal-title":"Veterinary Journal (London England 1997)"},{"key":"10.1016\/j.tvjl.2026.106703_bib27","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1007\/s12272-011-1112-1","article-title":"Controlled release chitosan microspheres of mirtazapine: in vitro and in vivo evaluation","volume":"34","author":"Ranjan","year":"2011","journal-title":"Archives of Pharmacal Research"},{"key":"10.1016\/j.tvjl.2026.106703_bib28","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1093\/chromsci\/47.3.223","article-title":"Development and validation of a reversed-phase HPLC method for separation and simultaneous determination of process-related substances of mirtazapine in bulk drugs and formulations","volume":"47","author":"Rao","year":"2009","journal-title":"Journal of Chromatographic Science"},{"key":"10.1016\/j.tvjl.2026.106703_bib29","doi-asserted-by":"crossref","first-page":"315","DOI":"10.3109\/10837450.2010.535828","article-title":"Preparation and evaluation of taste-masked dextromethorphan oral disintegrating tablet","volume":"17","author":"Samprasit","year":"2012","journal-title":"Pharmaceutical Development and Technology"},{"key":"10.1016\/j.tvjl.2026.106703_bib30","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1080\/10837450.2018.1462471","article-title":"Orally disintegrating tablets, fast-dissolving, buccal and sublingual formulations","volume":"23","author":"\u015eenel","year":"2018","journal-title":"Pharmaceutical Development and Technology"},{"key":"10.1016\/j.tvjl.2026.106703_bib31","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.jveb.2023.06.001","article-title":"Effects of transdermal mirtazapine and oral gabapentin as pre-veterinary visit pharmaceuticals for shelter cats","volume":"64-65","author":"Spano","year":"2023","journal-title":"J. Vet. Behav. Clin Appl. Res."},{"key":"10.1016\/j.tvjl.2026.106703_bib32","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics14040859","article-title":"Puzzle out machine learning model-explaining disintegration process in ODTs","volume":"14","author":"Szl\u0119k","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.tvjl.2026.106703_bib33","first-page":"249","article-title":"Cationic Eudragit\u00ae polymers as excipients for microparticles prepared by solvent evaporation method","volume":"62","author":"Vyslou\u017eil","year":"2013","journal-title":"Ceska a Slovenska farmacie Casopis Ceske farmaceuticke spolecnosti a Slovenske farmaceuticke spolecnosti"},{"key":"10.1016\/j.tvjl.2026.106703_bib34","doi-asserted-by":"crossref","DOI":"10.3390\/ma12203386","article-title":"Ethylcellulose-A pharmaceutical excipient with multidirectional application in drug dosage forms development","volume":"12","author":"Wasilewska","year":"2019","journal-title":"Materials"},{"key":"10.1016\/j.tvjl.2026.106703_bib35","doi-asserted-by":"crossref","first-page":"2947","DOI":"10.1007\/s11095-023-03605-x","article-title":"Investigating the Impact of Co-processed Excipients on the Formulation of Bromhexine Hydrochloride Orally Disintegrating Tablets (ODTs)","volume":"40","author":"Woyna-Orlewicz","year":"2023","journal-title":"Pharmaceutical Research"},{"key":"10.1016\/j.tvjl.2026.106703_bib36","doi-asserted-by":"crossref","first-page":"G796","DOI":"10.1152\/ajpgi.00130.2013","article-title":"Prokinetic effects of mirtazapine on gastrointestinal transit","volume":"306","author":"Yin","year":"2014","journal-title":"American Journal of Physiology Gastrointestinal and liver Physiology"},{"key":"10.1016\/j.tvjl.2026.106703_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2019.105108","article-title":"Preparation and evaluation of novel multi-channel orally disintegrating tablets","volume":"142","author":"Yu","year":"2020","journal-title":"European Journal of Pharmaceutical Sciences Official Journal of the European Federation for Pharmaceutical Sciences"}],"container-title":["The Veterinary Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1090023326001590?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1090023326001590?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T01:09:25Z","timestamp":1780016965000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1090023326001590"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":37,"alternative-id":["S1090023326001590"],"URL":"https:\/\/doi.org\/10.1016\/j.tvjl.2026.106703","relation":{},"ISSN":["1090-0233"],"issn-type":[{"value":"1090-0233","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Overcoming mirtazapine's therapeutic limitations in veterinary practice: Development of a taste\u00a0-\u00a0masked orally disintegrating tablet with microsphere-based controlled release","name":"articletitle","label":"Article Title"},{"value":"The Veterinary Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tvjl.2026.106703","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"106703"}}